{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.510","meta":{"versionId":"5","lastUpdated":"2018-07-24T01:07:49.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.510","version":"20180724","name":"Patient Reasons for Not Performing Flow Cytometry","status":"active","date":"2018-07-24T01:00:01-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","concept":[{"code":"2P","display":"Performance Measure Exclusion Modifier due to Patient Reasons"},{"code":"3170F","display":"Flow cytometry studies performed at time of diagnosis or prior to initiating treatment (HEM)"}]}]},"expansion":{"identifier":"urn:uuid:67d74c52-d47a-4b32-9844-e97b3495cf0f","timestamp":"2022-06-10T10:47:49-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"2P","display":"Performance Measure Exclusion Modifier due to Patient Reasons"},{"system":"http://www.ama-assn.org/go/cpt","version":"2021","code":"3170F","display":"Baseline flow cytometry studies performed at time of diagnosis or prior to initiating treatment (HEM)"}]}}